文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2016 年全球 195 个国家/地区下呼吸道感染的发病率、死亡率和病因的全球、区域和国家估计值:2016 年全球疾病负担研究的系统分析。

Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

出版信息

Lancet Infect Dis. 2018 Nov;18(11):1191-1210. doi: 10.1016/S1473-3099(18)30310-4. Epub 2018 Sep 19.


DOI:10.1016/S1473-3099(18)30310-4
PMID:30243584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6202443/
Abstract

BACKGROUND: Lower respiratory infections are a leading cause of morbidity and mortality around the world. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016, provides an up-to-date analysis of the burden of lower respiratory infections in 195 countries. This study assesses cases, deaths, and aetiologies spanning the past 26 years and shows how the burden of lower respiratory infection has changed in people of all ages. METHODS: We used three separate modelling strategies for lower respiratory infections in GBD 2016: a Bayesian hierarchical ensemble modelling platform (Cause of Death Ensemble model), which uses vital registration, verbal autopsy data, and surveillance system data to predict mortality due to lower respiratory infections; a compartmental meta-regression tool (DisMod-MR), which uses scientific literature, population representative surveys, and health-care data to predict incidence, prevalence, and mortality; and modelling of counterfactual estimates of the population attributable fraction of lower respiratory infection episodes due to Streptococcus pneumoniae, Haemophilus influenzae type b, influenza, and respiratory syncytial virus. We calculated each modelled estimate for each age, sex, year, and location. We modelled the exposure level in a population for a given risk factor using DisMod-MR and a spatio-temporal Gaussian process regression, and assessed the effectiveness of targeted interventions for each risk factor in children younger than 5 years. We also did a decomposition analysis of the change in LRI deaths from 2000-16 using the risk factors associated with LRI in GBD 2016. FINDINGS: In 2016, lower respiratory infections caused 652 572 deaths (95% uncertainty interval [UI] 586 475-720 612) in children younger than 5 years (under-5s), 1 080 958 deaths (943 749-1 170 638) in adults older than 70 years, and 2 377 697 deaths (2 145 584-2 512 809) in people of all ages, worldwide. Streptococcus pneumoniae was the leading cause of lower respiratory infection morbidity and mortality globally, contributing to more deaths than all other aetiologies combined in 2016 (1 189 937 deaths, 95% UI 690 445-1 770 660). Childhood wasting remains the leading risk factor for lower respiratory infection mortality among children younger than 5 years, responsible for 61·4% of lower respiratory infection deaths in 2016 (95% UI 45·7-69·6). Interventions to improve wasting, household air pollution, ambient particulate matter pollution, and expanded antibiotic use could avert one under-5 death due to lower respiratory infection for every 4000 children treated in the countries with the highest lower respiratory infection burden. INTERPRETATION: Our findings show substantial progress in the reduction of lower respiratory infection burden, but this progress has not been equal across locations, has been driven by decreases in several primary risk factors, and might require more effort among elderly adults. By highlighting regions and populations with the highest burden, and the risk factors that could have the greatest effect, funders, policy makers, and programme implementers can more effectively reduce lower respiratory infections among the world's most susceptible populations. FUNDING: Bill & Melinda Gates Foundation.

摘要

背景:下呼吸道感染是全世界发病率和死亡率的主要原因。全球疾病、伤害和危险因素研究 2016 年(GBD 2016)提供了最新的分析,研究了 195 个国家的下呼吸道感染负担。本研究评估了过去 26 年的病例、死亡和病因,并展示了下呼吸道感染在所有年龄段人群中的负担是如何变化的。

方法:我们在 GBD 2016 中使用了三种独立的下呼吸道感染建模策略:一个贝叶斯分层集成建模平台(死因集成模型),该模型使用人口登记、死因推断数据和监测系统数据来预测下呼吸道感染导致的死亡率;一个分类回归工具(DisMod-MR),该工具使用科学文献、代表性人口调查和医疗保健数据来预测发病率、患病率和死亡率;以及对肺炎链球菌、流感嗜血杆菌 b 型、流感和呼吸道合胞病毒导致的下呼吸道感染事件的人群归因分数的反事实估计的建模。我们为每个年龄、性别、年份和地点计算了每个模型的估计值。我们使用 DisMod-MR 和时空高斯过程回归来计算特定风险因素下的人群暴露水平,并评估了针对 5 岁以下儿童的每个风险因素的靶向干预措施的效果。我们还使用 2016 年 GBD 中与下呼吸道感染相关的风险因素对 2000-16 年下呼吸道感染死亡人数的变化进行了分解分析。

结果:2016 年,下呼吸道感染导致 5 岁以下儿童(<5 岁)死亡 652572 例(95%置信区间 [95%UI]:586475-720612),70 岁以上成年人死亡 1080958 例(943749-1170638),所有年龄组死亡 2377697 例(2145584-2512809),全球范围。肺炎链球菌是全球下呼吸道感染发病率和死亡率的主要原因,2016 年导致的死亡人数超过所有其他病因的总和(1189937 例,95%UI:690445-1770660)。儿童消瘦仍然是导致 5 岁以下儿童下呼吸道感染死亡的主要危险因素,占 2016 年下呼吸道感染死亡人数的 61.4%(95%UI:45.7-69.6)。改善消瘦、家庭空气污染、环境颗粒物污染和扩大抗生素使用范围等干预措施,可能会使每治疗 4000 名负担最重下呼吸道感染的国家中的儿童,就避免 1 名儿童死于下呼吸道感染。

解释:我们的研究结果表明,下呼吸道感染负担的减少取得了实质性进展,但这种进展在不同地区并不均衡,主要是由于几个主要危险因素的减少,而且在老年人群中可能需要付出更多的努力。通过突出负担最重的地区和人群,以及可能产生最大影响的风险因素,资助者、政策制定者和方案实施者可以更有效地减少世界上最易受感染人群的下呼吸道感染。

资金来源:比尔及梅琳达·盖茨基金会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced2/6202443/198967c0f6eb/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced2/6202443/88605da201c2/gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced2/6202443/e26d5fd04ec9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced2/6202443/3ffba02da03b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced2/6202443/198967c0f6eb/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced2/6202443/88605da201c2/gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced2/6202443/e26d5fd04ec9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced2/6202443/3ffba02da03b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced2/6202443/198967c0f6eb/gr4a.jpg

相似文献

[1]
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet Infect Dis. 2018-9-19

[2]
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet Infect Dis. 2018-9-19

[3]
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015.

Lancet Infect Dis. 2017-11

[4]
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.

Lancet Infect Dis. 2024-9

[5]
Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019.

Lancet Infect Dis. 2022-11

[6]
Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017.

Lancet Infect Dis. 2019-10-31

[7]
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[8]
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet Infect Dis. 2024-7

[9]
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet. 2018-11-8

[10]
Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015.

Lancet Infect Dis. 2017-9

引用本文的文献

[1]
Resource Allocation in the Pediatric Intensive Care Unit in Rwanda.

Ann Glob Health. 2025-8-26

[2]
Serotype 3 pneumococcal pleural empyema: a case report and review of the epidemiology.

Eur Clin Respir J. 2025-8-27

[3]
Assessing the impact of childhood pneumococcal vaccination on pneumonia mortality in Colombia: a 14-year analysis.

BMC Public Health. 2025-9-1

[4]
The bacterial etiology and antimicrobial susceptibility of lower respiratory tract infections in Vietnam.

Ann Clin Microbiol Antimicrob. 2025-8-31

[5]
Safety and Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Chinese Children, Adults and the Elderly: A Phase 4, Randomized, Double-Blind, Active-Controlled Clinical Trial.

Vaccines (Basel). 2025-8-15

[6]
The role of cerebral oxygenation in pediatric lower respiratory tract infections based on insights from time domain near infrared spectroscopy tissue oximetry.

Sci Rep. 2025-8-25

[7]
Lower serum GPX4 and GSH/GSSG ratio are associated with poor prognosis in severe community-acquired pneumonia.

Eur J Med Res. 2025-8-21

[8]
Cost-effectiveness of a 13-valent pneumococcal conjugate vaccine compared with currently available pneumococcal conjugate vaccines in Indian children.

IJID Reg. 2025-7-16

[9]
Effects of oral zinc supplementation in the prevention of community-acquired pneumonia in colombian children: an economic evaluation : Short running title: Cost-effectiveness analysis oral zinc supplementation.

BMC Public Health. 2025-8-15

[10]
Study on the 1990-2021 trend of global childhood respiratory infection and tuberculosis disease burden and related risk factors.

Front Public Health. 2025-7-30

本文引用的文献

[1]
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Lancet. 2017-12-14

[2]
The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review.

Vaccine. 2017-11-20

[3]
Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study.

Lancet. 2017-11-14

[4]
Mapping under-5 and neonatal mortality in Africa, 2000-15: a baseline analysis for the Sustainable Development Goals.

Lancet. 2017-9-25

[5]
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 2017-9-16

[6]
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 2017-9-16

[7]
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 2017-9-16

[8]
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 2017-9-16

[9]
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015.

Lancet Infect Dis. 2017-11

[10]
Stunting, Wasting and Underweight in Sub-Saharan Africa: A Systematic Review.

Int J Environ Res Public Health. 2017-8-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索